Doug Gentilcore's most recent trade in Y-Mabs Therapeutics Inc was a trade of 142,600 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Doug Gentilcore | SVP, Danyelza Bus. Unit Head | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 142,600 | 142,600 | - | - | Employee Stock Option (right to buy) |